Suppression of vascular endothelial growth factor via siRNA interference modulates the biological behavior of human nasopharyngeal carcinoma cells

Japanese Journal of Radiology

Volumn 29, Issue 9, 2011, Pages 615-622

  Zhou, Hai B ^a,b   Yin, Yi F ^a   Hu, Yan ^a   Li, Xin ^a   Zou, Li Y ^a   Li, Yong J ^a   Gu, Yu ^a   Ou, Bao Q ^a   Fu, Juan ^a   Du, Jun H ^a   Wu, Gang ^b  

^a Second Hospital of Yichang   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Apoptosis; CNE 2 cell line; Radiosensitivity; SiRNA; VEGF

Indexed keywords

LIPOFECTAMINE; MESSENGER RNA; SMALL INTERFERING RNA; VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE ARREST; CELL INVASION; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; NASOPHARYNX CARCINOMA; PLASMID; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHI-SQUARE DISTRIBUTION; DOWN-REGULATION; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; HUMANS; NASOPHARYNGEAL NEOPLASMS; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 81855227695     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-011-0603-9     Document Type: Article

References (47)

1. McBride WH, Chiang CS, Olson JL, Wang CC, Hong JH, Pajonk F, et al. A sense of danger from radiation. Radiat Res 2004;162:1-19. (Pubitemid 39044714)
2. Borgmann K, Roper B, El-Awady R, Brackrock S, Bigalke M, Dork T, et al. Indicators of late normal tissue response after radiotherapy for head and neck cancer: Fi broblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. Radiother Oncol 2002;64:141-52. (Pubitemid 35247891)
3. Hingorani M, White CL, Agrawal VK, Vidal L, Melcher A, Harrington KJ. Combining radiation and cancer gene therapy: A potential marriage of physical and biological targeting? Curr Cancer Drug Targets 2007;7:389-409. (Pubitemid 46850697)
4. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectaltumor development. N Engl J Med 1988;319:525-32.
5. Stevens CW, Zeng M, Cerniglia GJ. Ionizing radiation greatly improves gene transfer efficiency in mammalian cells. Hum Gene Ther 1996;7:1727-34. (Pubitemid 26340484)
6. Zeng M, Cerniglia GJ, Eck SL, Stevens CW. High-efficiency stable gene transfer of adenovirus into mammalian cells using ionizing radiation. Hum Gene Ther 1997;8:1025-32. (Pubitemid 27308200)
7. Hsu H, Rainov NG, Quinones A, Eling DJ, Sakamoto KM, Spear MA. Combined radiation and cytochrome CYP4B1/4- ipomeanol gene therapy using the EGR1 promoter. Anticancer Res 2003;23:2723-8.
8. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6. (Pubitemid 20020880)
9. Ferrara N. VEGF and the quest for tumor angiogenesis factors. Nat Rev Cancer 2002;2:795-803. (Pubitemid 37328914)
10. Ellis LM, Takahashi Y, Fenoglio CJ, Cleary KR, Bucana CD, Evans DB. Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. Eur J Cancer 1998;34:337-40. (Pubitemid 28183830)
11. Sowter HM, Corps AN, Evans AL, Clark DE, Charnock- Jones DS, Smith SK. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. Lab Invest 1997;77:607-14. (Pubitemid 28018781)
12. Tomisawa M, Tokunaga T, Oshika Y. Expression pattern of vascular endothelial growth factor isoform is closely correlated with tumour stage and vascularisation in renal cell carcinoma. Eur J Cancer 1999;35:133-7. (Pubitemid 29079504)
13. Volm M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer. Int J Cancer 1997;74:64-8. (Pubitemid 27157857)
14. Yoshiji H, Gomez DE, Shibuya M, Thorgeirsson UP. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res 1996;56:2013-6. (Pubitemid 26119899)
15. Elbashir SM, Lendeckel W, Tuschl T. RNA interference is mediated by 21 and 22-nucleotide RNAs. Genes Dev 2001;15: 188-200. (Pubitemid 32107664)
16. Fire A, Xu SQ, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by doublestranded RNA in Caenorhabditis elegans. Nature 1998;391: 806-11. (Pubitemid 28099681)
17. Martinez J, Patkaniowska A, Urlaub H, Luhrmann R, Tuschl T. Single stranded antisense siRNAs guide target RNA cleavage in RNAi. Cell 2002;110:563-74. (Pubitemid 35247837)
18. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002;32:107-8. (Pubitemid 34977204)
19. Tao J, Tu YT, Zhang XB. Construction and identification of pU-VEGF-siRNA expression vector. Chin J Derm Venereol 2006;20:134-7.
20. McBride WH, Chiang CS, Olson JL. A sense of danger from radiation. Radiat Res 2004;162:1-19. (Pubitemid 39044714)
21. Borgmann K, Roper B, El-Awady R. Indicators of late normal tissue response after radiotherapy for head and neck cancer: Fi broblasts, lymphocytes, genetics, DNA repair, and chromosome aberrations. Radiother Oncol 2002;l64:141-52. (Pubitemid 35247891)
22. Swisher SG, Roth JA, Komaki R, Gu J, Lee JJ, Hicks M, et al. Induction of p53-regulated genes and tumor regression in lung cancer patients after intratumoral delivery of adenoviral p53 (INGN201) and radiation therapy. Clin Cancer Res 2003;9:93-101. (Pubitemid 36109720)
23. Kufe D, Weichselbaum R. Radiation therapy: Activation of gene transcription and the development of genetic radiotherapy. Cancer Biol Ther 2003;2:326-9.
24. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005;23:1011-27. (Pubitemid 46202320)
25. Soria JC, Fayette J, Armand JP. Molecular targeting: Targeting angiogenesis in solid tumors. Ann Oncol 2004;15:223-7.
26. Bachelder RE, Crago A, Chung J. Vascular endothelial growth factor is an autocrine survival factor for neuropilinexpressing breast carcinoma cells. Cancer Res 2001;61: 5736-40. (Pubitemid 32769088)
27. Bachelder RE, Wendt MA, Mercurio AM. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res 2002;62:7203-6.
28. Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS. Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 2001;98:1904-13.
29. Schoeffner DJ, Matheny SL, Akahane T. VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms. Lab Invest 2005;85:608-23. (Pubitemid 40675442)
30. Detwiller KY, Fernando NT, Segal NH, Ryeom SW, D'Amore PA, Yoon SS. Analysis of hypoxia-related gene expression in sarcomas and effect of hypoxia on RNA interference of vascular endothelial cell growth factor A. Cancer Res 2005;65: 5881-9. (Pubitemid 40911194)
31. Guan H, Zhou ZC, Wang H, Jia SF, Liu WB, Kleinerman ES. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model. Clin Cancer Res 2005;11:2662-9. (Pubitemid 40569467)
32. La Rosa S, Uccella S, Finzi G, Albarello L, Sessa F, Capella C. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: Correlation with microvessel density and clinicopathologic features. Hum Pathol 2003;34:18-27. (Pubitemid 36160017)
33. Waltenberger, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin CH. Different signal transduction properties of KDR and Fit1, two receptors for vascular endothelial growth factor. J Biol Chem 1994;269:26988-95. (Pubitemid 24332901)
34. Yin Y, Cao LY, Wu WQ, Li H, Jiang Y, Zhang HF. Blocking effects of siRNA on VEGF expression in human colorectal cancer cells. World J Gastroenterol 2010;16:1086-92.
35. Zhai XY. The significance of VEGF, TNF-á and receptor VEGFR1, P55 in epithelium tissue of human rhinocarcinoma. Med Sci Philos 2009;390:59-61.
36. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate interference in cultured mammalian cells. Nature 2001;411:494-8.
37. Murata N, Takashima Y, Toyoshima K, Yamamoto M, Okada H. Anti-tumor effects of anti-VEGF siRNA encapsulated with PLGA microspheres in mice. J Controlled Release 2008;126:246-54.
38. Raskopf E, Vogt A, Sauerbruch T, Schmitz V. SiRNA targeting VEGF inhibits hepatocellular carcinoma growth and tumor angiogenesis in vivo. J Hepatol 2008;49:977-84.
39. Chen Z, Varney ML, Backora MW, Cowan K, Solheim JC, Talmadge JE, et al. Down-regulation of vascular endothelial cell growth factor-C expression using small interfering RNA vectors in mammary tumors inhibits tumor lymphangiogenesis and spontaneous metastasis and enhances survival. Cancer Res 2005;65:9004-11. (Pubitemid 41377392)
40. Xiao-wen HE, Xiao YU, Ting LIU, Shi-yi YU, Dao-jin C. Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice. Chin Med J 2008;121: 439-44.
41. Mulkeen AL, Silva T, Yoo PS, Schmitz JC, Uchio E, Chu E, et al. Short interfering RNA-mediated gene silencing of vascular endothelial growth factor. Arch Surg 2006;141:367-74.
42. Nieder C, Wiedenmann N, Andratschke N, Moll MS. Current status of angiogenesis inhibitors combined with radiation therapy. Cancer Treat Rev 2006;32:348-64. (Pubitemid 44063875)
43. Langeland Marthinsen AB, Aybdahl Wanderas A. Effects of growth factors on growth and radiation sensitivity of the human breast cancer cell line T-47D. Oncol Rep 2002;9: 397-403.
44. Shintani S, Kiyota A, Mihara M. Association of preoperative radiation effect with tumor angiogenesis and vascular endothelial growth factor in oral squamous cell carcinoma. Jpn J Cancer Res 2000;91:1051-7.
45. Filleur S, Courtin A, Ait-Si-Ali S, Guglielmi J, Merle C, Harel-Bellan A, et al. SiRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to antiangiogenic thrombospondin-1 and slows tumor vascularization and growth 1. Cancer Res 2003;63:3919-22. (Pubitemid 36917906)
46. McLoughlin M, Fuks Z, Kolesnick RN. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 1994;180:525-35. (Pubitemid 24224129)
47. Wachsberger P, Burd R, Dicker AP. Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: Exploring mechanisms of interaction. Clin Cancer Res 2003;9:1957-71. (Pubitemid 36687614)